M&A Deal Summary |
|
---|---|
Date | 2015-02-18 |
Target | BioSurface Engineering Technologies |
Sector | Medical Products |
Buyer(s) | Ferring Pharmaceuticals |
Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
Ferring is a research-driven, specialty biopharmaceutical group active in global markets. The company identifies, develops and markets innovative products in the areas of reproductive health, urology, gastroenterology, endocrinology and orthopaedics. Ferring has its own operating subsidiaries in nearly 60 countries and markets its products in 110 countries. Ferring is headquartered in Saint-Prex, Switzerland.
DEAL STATS | # |
---|---|
Overall | 1 of 3 |
Sector (Medical Products) | 1 of 2 |
Type (Add-on Acquisition) | 1 of 2 |
State (Maryland) | 1 of 1 |
Country (United States) | 1 of 3 |
Year (2015) | 1 of 2 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2015-09-28 |
MILPROSA
United States MILPROSA is a soft, flexible silicone-based vaginal ring designed to deliver a daily 11 mg dose of progesterone over the course of one week. |
Buy | - |